TherapeuticsMD, Inc. (TXMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for TherapeuticsMD, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -33.14x | -4.55x | -2.29x | 0.45x | -0.83x | -1.82x |
| P/B Ratio | 0.70x | 0.36x | 0.80x | 1.44x | -1.53x | -2.69x |
| P/S Ratio | 6.24x | 5.63x | 18.04x | 0.72x | 55.69x | 5.14x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 98.0% | 45.5% | 75.4% |
| Operating Margin | -139.4% | -270.3% | -654.6% | 1.7% | -3092.8% | -239.8% |
| Net Margin | -18.8% | -123.8% | -789.4% | 160.1% | -6700.9% | -282.9% |
| EBITDA Margin | -100.0% | -169.4% | -620.9% | 17.0% | -2753.2% | -236.5% |
| Liquidity | ||||||
| Current Ratio | 3.02x | 1.92x | 1.72x | 1.18x | 0.47x | 2.17x |
| Quick Ratio | 3.02x | 1.92x | 1.72x | 1.18x | 0.44x | 2.03x |
| Leverage | ||||||
| Debt/Equity | 0.19x | 0.26x | 0.27x | 0.25x | -2.11x | -2.01x |
YoY = year-over-year change. Source: FMP..